Refreshing results…
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer
Download from doi.orgA Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
UploadImmune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
Download from link.springer.comImmune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
Download from link.springer.comMissing publications? Search for publications with a matching author name.